{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:38:03Z","timestamp":1777394283769,"version":"3.51.4"},"reference-count":42,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2015,10,1]]},"DOI":"10.3233\/jad-150351","type":"journal-article","created":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T12:08:24Z","timestamp":1444133304000},"page":"637-646","source":"Crossref","is-referenced-by-count":45,"title":["Increased Cerebrospinal Fluid Level of\u00a0Insulin-like Growth Factor-II in Male Patients with Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"48","author":[{"given":"Daniel","family":"\u00c5berg","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Johansson","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Neuropsychiatry, Skaraborg Hospital, Falk\u00f6ping, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rgen","family":"Isgaard","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Wallin","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, M\u00f6lndal, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Ove","family":"Johansson","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Andreasson","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, M\u00f6lndal, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, M\u00f6lndal, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, M\u00f6lndal, Sweden"},{"name":"UCL Institute of Neurology, Queen Square, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. David","family":"\u00c5berg","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Svensson","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Endocrinology, Skaraborg Hospital, Sk\u00f6vde, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-150351_ref1","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1210\/er.2004-0024","article-title":"The insulin-like growth factor system and its pleiotropic functions in brain","volume":"26","author":"Russo","year":"2005","journal-title":"Endocr Rev"},{"key":"10.3233\/JAD-150351_ref2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.yfrne.2012.06.002","article-title":"Neurodevelopmental effects of insulin-like growth factor signaling","volume":"33","author":"O\u2019Kusky","year":"2012","journal-title":"Front Neuroendocrinol"},{"key":"10.3233\/JAD-150351_ref3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF02257671","article-title":"Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type","volume":"5","author":"Tham","year":"1993","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"10.3233\/JAD-150351_ref4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0304-3940(98)00829-5","article-title":"Insulin-like growth factor system in serum and cerebrospinal fluid in patients with multiple sclerosis","volume":"257","author":"Wilczak","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-150351_ref5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1203\/01.PDR.0000156369.62787.96","article-title":"Early developmental changes in IGF-I, IGF-II, IGF binding protein-1, and IGF binding protein-3 concentration in the cerebrospinal fluid of children","volume":"58","author":"Bunn","year":"2005","journal-title":"Pediatr Res"},{"key":"10.3233\/JAD-150351_ref6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/biof.5520330202","article-title":"Insulin like growth factor-1 and insulin like growth factor binding proteins in the cerebrospinal fluid and serum from patients with Alzheimer\u2019s disease","volume":"33","author":"Salehi","year":"2008","journal-title":"Biofactors"},{"key":"10.3233\/JAD-150351_ref7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jocn.2009.08.013","article-title":"Expression of insulin-like growth factor-1 and insulin-like growth factor binding proteins in the serum and cerebrospinal fluid of patients with Parkinson\u2019s disease","volume":"17","author":"Mashayekhi","year":"2010","journal-title":"J Clin Neurosci"},{"key":"10.3233\/JAD-150351_ref8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrn3209","article-title":"The many faces of insulin-like peptide signalling in the brain","volume":"13","author":"Fernandez","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-150351_ref9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainresrev.2003.11.002","article-title":"The insulin-like growth factor-II\/mannose-6 phosphate receptor: Structure, distribution and function in the central nervous system","volume":"44","author":"Hawkes","year":"2004","journal-title":"Brain Res Brain Res Rev"},{"key":"10.3233\/JAD-150351_ref10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1523\/JNEUROSCI.2730-05.2006","article-title":"Single transmembrane domain insulin-like growth factor-II\/mannose-6-phosphate receptor regulates central cholinergic function by activating a G-protein-sensitive, protein kinase C-dependent pathway","volume":"26","author":"Hawkes","year":"2006","journal-title":"J Neurosci"},{"issue":"Suppl 2","key":"10.3233\/JAD-150351_ref11","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.3233\/JAD-2012-111727","article-title":"Triangulated mal-signaling in Alzheimer\u2019s disease: Roles of neurotoxic ceramides, ER stress, and insulin resistance reviewed","volume":"30","author":"de la Monte","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150351_ref12","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nm1202-793","article-title":"Serum insulin-like growth factor I regulates brain amyloid-beta levels","volume":"8","author":"Carro","year":"2002","journal-title":"Nat Med"},{"key":"10.3233\/JAD-150351_ref13","doi-asserted-by":"crossref","first-page":"10884","DOI":"10.1523\/JNEUROSCI.2909-05.2005","article-title":"Choroid plexus megalin is involved in neuroprotection by serum insulin-like growth factor I","volume":"25","author":"Carro","year":"2005","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-150351_ref14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3233\/JAD-2005-8304","article-title":"Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer\u2019s disease: Link to brain reductions in acetylcholine","volume":"8","author":"Rivera","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150351_ref15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease \u2013 is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150351_ref16","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-150351_ref17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2377-14-64","article-title":"Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer\u2019s disease: An observational study","volume":"14","author":"Hertze","year":"2014","journal-title":"BMC Neurol"},{"key":"10.3233\/JAD-150351_ref18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nature09667","article-title":"A critical role for IGF-II in memory consolidation and enhancement","volume":"469","author":"Chen","year":"2011","journal-title":"Nature"},{"key":"10.3233\/JAD-150351_ref19","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.neuroscience.2010.07.026","article-title":"Leu27 insulin-like growth factor-II, an insulin-like growth factor-II analog, attenuates depolarization-evoked GABA release from adult rat hippocampal and cortical slices","volume":"170","author":"Amritraj","year":"2010","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-150351_ref20","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3233\/JAD-132183","article-title":"The role of IGF-I, IGF-II, and IGFBP-3 in male cognitive aging and dementia risk: The Caerphilly Prospective Study","volume":"41","author":"Green","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150351_ref21","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.15252\/emmm.201404228","article-title":"Insulin-like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice","volume":"6","author":"Pascual-Lucas","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-150351_ref22","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00213-012-2841-7","article-title":"Galantamine increases hippocampal insulin-like growth factor 2 expression via \u03b17 nicotinic acetylcholine receptors in mice","volume":"225","author":"Kita","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.3233\/JAD-150351_ref23","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1523\/JNEUROSCI.0111-12.2012","article-title":"I\u03baB kinase\/nuclear factor \u03baB-dependent insulin-like growth factor 2 (Igf2) expression regulates synapse formation and spine maturation via Igf2 receptor signaling","volume":"32","author":"Schmeisser","year":"2012","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-150351_ref24","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/npp.2014.69","article-title":"Enhancement of memories by systemic administration of insulin-like qrowth factor II","volume":"39","author":"Stern","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.3233\/JAD-150351_ref25","doi-asserted-by":"crossref","first-page":"e94287","DOI":"10.1371\/journal.pone.0094287","article-title":"IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer\u2019s disease model mice","volume":"9","author":"Mellott","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/JAD-150351_ref26","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.psyneuen.2013.02.006","article-title":"Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer\u2019s disease","volume":"38","author":"Johansson","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.3233\/JAD-150351_ref27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejphar.2004.02.050","article-title":"The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer\u2019s disease","volume":"490","author":"Carro","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.3233\/JAD-150351_ref28","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1038\/tp.2013.102","article-title":"Loss of serum IGF-I input to the brain as an early biomarker of disease onset in Alzheimer mice","volume":"3","author":"Trueba-S\u00e1iz","year":"2013","journal-title":"Transl Psychiatry"},{"key":"10.3233\/JAD-150351_ref29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3233\/JAD-2011-101878","article-title":"Cerebrospinal fluid biomarkers for Alzheimer\u2019s disease: Diagnostic performance in a homogeneous mono-center population","volume":"24","author":"Johansson","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150351_ref30","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.3233\/JAD-150351_ref31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop","volume":"43","author":"Rom\u00e1n","year":"1993","journal-title":"Neurology"},{"key":"10.3233\/JAD-150351_ref32","first-page":"23","article-title":"Research criteria for subcortical vascular dementia in clinical trials","volume":"59","author":"Erkinjuntti","year":"2000","journal-title":"Neural Transm Suppl"},{"key":"10.3233\/JAD-150351_ref33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"key":"10.3233\/JAD-150351_ref34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-150351_ref35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/13506120009146438","article-title":"Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma","volume":"7","author":"Vanderstichele","year":"2000","journal-title":"Amyloid"},{"key":"10.3233\/JAD-150351_ref36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02815140","article-title":"Tau protein in cerebrospinal fluid: A biochemical marker for axonal degeneration in Alzheimer disease?","volume":"26","author":"Blennow","year":"1995","journal-title":"Mol Chem Neuropathol"},{"key":"10.3233\/JAD-150351_ref37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3940(00)01036-3","article-title":"Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: A sandwich ELISA with a synthetic phosphopeptide for standardization","volume":"285","author":"Vanmechelen","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-150351_ref38","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1210\/endo.135.5.7525264","article-title":"Coordinated pattern of expression and localization of insulin-like growth factor-II (IGF-II) and IGF-binding protein-2 in the adult rat brain","volume":"135","author":"Logan","year":"1994","journal-title":"Endocrinology"},{"key":"10.3233\/JAD-150351_ref39","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2337\/diab.35.6.654","article-title":"Binding and internalization of insulin and insulin-like growth factors by isolated brain microvessels","volume":"35","author":"Frank","year":"1986","journal-title":"Diabetes"},{"key":"10.3233\/JAD-150351_ref40","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1210\/jc.2012-2063","article-title":"Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Alzheimer\u2019s disease","volume":"97","author":"Duron","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.3233\/JAD-150351_ref41","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1210\/endo.140.12.7169","article-title":"Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain","volume":"140","author":"Hoeflich","year":"1999","journal-title":"Endocrinology"},{"key":"10.3233\/JAD-150351_ref42","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/endo.142.5.8149","article-title":"Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2","volume":"142","author":"Hoeflich","year":"2001","journal-title":"Endocrinology"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-150351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:02:52Z","timestamp":1777370572000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-150351"}},"subtitle":[],"editor":[{"given":"Laura","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,1]]},"references-count":42,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-150351","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,1]]}}}